CN101190322A - Traditional Chinese medicine for treating zoster post herpetic neuralgia - Google Patents
Traditional Chinese medicine for treating zoster post herpetic neuralgia Download PDFInfo
- Publication number
- CN101190322A CN101190322A CNA2006101316647A CN200610131664A CN101190322A CN 101190322 A CN101190322 A CN 101190322A CN A2006101316647 A CNA2006101316647 A CN A2006101316647A CN 200610131664 A CN200610131664 A CN 200610131664A CN 101190322 A CN101190322 A CN 101190322A
- Authority
- CN
- China
- Prior art keywords
- radix
- herpetic neuralgia
- chinese medicine
- medicine
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 30
- 206010036376 Postherpetic Neuralgia Diseases 0.000 title claims abstract description 16
- 208000007514 Herpes zoster Diseases 0.000 title 1
- 210000000582 semen Anatomy 0.000 claims abstract description 9
- 239000010231 banlangen Substances 0.000 claims abstract description 8
- 244000111489 Gardenia augusta Species 0.000 claims abstract 2
- 238000011282 treatment Methods 0.000 claims description 21
- 235000014375 Curcuma Nutrition 0.000 claims description 7
- 239000002994 raw material Substances 0.000 claims description 3
- 244000164439 Curcuma angustifolia Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 6
- 230000008901 benefit Effects 0.000 abstract description 4
- 244000236521 Bupleurum rotundifolium Species 0.000 abstract 1
- 235000015221 Bupleurum rotundifolium Nutrition 0.000 abstract 1
- 244000163122 Curcuma domestica Species 0.000 abstract 1
- 235000003392 Curcuma domestica Nutrition 0.000 abstract 1
- 235000018958 Gardenia augusta Nutrition 0.000 abstract 1
- 240000002045 Guettarda speciosa Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 241000334154 Isatis tinctoria Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 235000003373 curcuma longa Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 235000013976 turmeric Nutrition 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 229940079593 drug Drugs 0.000 description 9
- 208000002193 Pain Diseases 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 8
- 230000036407 pain Effects 0.000 description 8
- 241000407170 Curcuma Species 0.000 description 6
- 241000157835 Gardenia Species 0.000 description 6
- 240000005373 Panax quinquefolius Species 0.000 description 5
- 235000003140 Panax quinquefolius Nutrition 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 238000009835 boiling Methods 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 238000007654 immersion Methods 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 3
- 241000207929 Scutellaria Species 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 208000004296 neuralgia Diseases 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 208000037920 primary disease Diseases 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 239000002918 waste heat Substances 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 208000003098 Ganglion Cysts Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 208000005400 Synovial Cyst Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 208000002352 blister Diseases 0.000 description 1
- 230000035568 catharsis Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 238000007905 drug manufacturing Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000035929 gnawing Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese traditional medicine used for treating postherpetic neuralgia, which aims at developing a Chinese traditional medicine used for treating postherpetic neuralgia by adopting the theory of Chinese traditional medicine. The formula of the invention includes magnet, turmeric, dyers woad leaf, radix isatidis, cape jasmine fruit, radix scutellariae, Chinese thorowax root, rehmanniae praeparatum, semen plantaginis, liquoric root, angelica and white paeony root. The invention has the advantages of low price, good curative effect, being not easy to recur and extremely good social and economic benefits. The total effective rate of the medicine of the invention can reach more than 94.70%.
Description
Technical field:
The invention belongs to the field of Chinese medicines, particularly relate to a kind of Chinese medicine for the treatment of post-herpetic neuralgia.
Background technology:
Post-herpetic neuralgia is commonly encountered diseases, the frequently-occurring disease of department of dermatologry and the department of neurology and the department of Chinese medicine, and it is funny by water---herpesvirus causes.Because the primary disease toxin can be hidden in dorsal ganglion for a long time, so still left over neuralgia after the herpes incrustation, some even delay difficulty are more given patient's life, study, work and are brought greatly painful mentally.At present, this disease still there is not specific treatment both at home and abroad.America and Europe and Japan and other countries are to the treatment of post-herpetic neuralgia, adopt cut off root of sympathetic nerve more, ethanol sealing or with treatments such as hormone, vitamin B group, analgesics, though pain is alleviated, but side effect is many, and cost an arm and a leg, treatment time longer relapse rate height and patient nearly shortcoming such as should not accept.
Summary of the invention:
The objective of the invention is to adopt theory of Chinese medical science, develop a kind of Chinese medicine for the treatment of post-herpetic neuralgia.
The present invention makes the raw materials of effective components weight portion and consists of:
Magnetitum 8～15 Radix Curcumaes 1～2 Folium Isatidis 5～10
Radix Isatidis 5～10 Fructus Gardeniaes 1～1.5 Radix Scutellariae 1.5～2.5
Radix Bupleuri 1～1.5 Radix Rehmanniae 1.5～2.5 Semen Plantaginiss 1～2
Radix Glycyrrhizae 0.5～1.5 Radix Angelicae Sinensis 1.5～2 Radix Paeoniae Albas 1.5～3
The present invention is cheap, good effect, and treatment time is short, should not recur, and social benefit, economic benefit are splendid.Medicine total effective rate of the present invention reaches more than 94.70%.
The specific embodiment:
The present invention makes the raw materials of effective components weight portion and consists of:
Magnetitum 8～15 Radix Curcumaes 1～2 Folium Isatidis 5～10
Radix Isatidis 5～10 Fructus Gardeniaes 1～1.5 Radix Scutellariae 1.5～2.5
Radix Bupleuri 1～1.5 Radix Rehmanniae 1.5～2.5 Semen Plantaginiss 1～2
Radix Glycyrrhizae 0.5～1.5 Radix Angelicae Sinensis 1.5～2 Radix Paeoniae Albas 1.5～3
Preparation method is:
1. said medicine is placed one and reinstate cold water immersion 30 minutes;
2. boiled 30 minutes with big fire;
3. use slow fire boiling instead;
4. use health gauze three layer filtration;
5. repeat above-mentioned steps, the herb liquid of obtaining for twice is placed in one glass, divide two parts;
6. press secondary every day, each 200ml one after each meal.
Embodiment 1:
Magnetitum 8 Radix Curcumaes 1 Folium Isatidis 5
Radix Isatidis 5 Fructus Gardeniaes 1 Radix Scutellariae 1.5
Radix Bupleuri 1 Radix Rehmanniae 1.5 Semen Plantaginiss 1
Radix Glycyrrhizae 0.5 Radix Angelicae Sinensis 1.5 Radix Paeoniae Albas 1.5
Preparation method is:
1. said medicine is placed one and reinstate cold water 500ml immersion 30 minutes;
2. boiled 30 minutes with big fire;
3. use slow fire boiling instead, medicinal liquid is surplus to be 100ml;
4. use health gauze three layer filtration;
5. repeat above-mentioned steps, the herb liquid of obtaining for twice is placed in one glass, divide two parts;
6. every part of 100ml, every day secondary, each 100ml one after each meal.
Embodiment 2:
Magnetitum 11.5 Radix Curcumaes 1.5 Folium Isatidiss 7.5
Radix Isatidis 7.5 Fructus Gardeniaes 1.25 Radix Scutellariaes 2
Radix Bupleuri 1.25 Radix Rehmanniae 2 Semen Plantaginiss 1.5
Radix Glycyrrhizae 1 Radix Angelicae Sinensis 1.75 Radix Paeoniae Albas 2.25
Preparation method is:
1. said medicine is placed one and reinstate cold water 1000ml immersion 30 minutes;
2. boiled 30 minutes with big fire;
3. use slow fire boiling instead, medicinal liquid is surplus to be 200ml;
4. use health gauze three layer filtration;
5. repeat above-mentioned steps, the herb liquid of obtaining for twice is placed in one glass, divide two parts;
6. every part of 200ml, every day secondary, each 200ml one after each meal.
Embodiment 3:
Magnetitum 15 Radix Curcumaes 2 Folium Isatidiss 10
Radix Isatidis 10 Fructus Gardeniaes 1.5 Radix Scutellariaes 2.5
Radix Bupleuri 1.5 Radix Rehmanniae 2.5 Semen Plantaginiss 2
Radix Glycyrrhizae 1.5 Radix Angelicae Sinensis 2 Radix Paeoniae Albas 3
Preparation method is:
1. said medicine is placed one and reinstate cold water 1500ml immersion 30 minutes;
2. boiled 30 minutes with big fire;
3. use slow fire boiling instead, medicinal liquid is surplus to be 200ml;
4. use health gauze three layer filtration;
5. repeat above-mentioned steps, the herb liquid of obtaining for twice is placed in one glass, divide two parts;
6. every part of 200ml, every day secondary, each 200ml one after each meal.
Clinical experiment of the present invention:
Drug therapy herpes neuralgia 315 examples of the present invention, matched group somedon treatment herpes neuralgia 79 examples, all cases all are diagnosed as the out-patient of post-herpetic neuralgia through No.1 Hospital of Jilin Univ.'s department of dermatologry or Neurology Department.
According to document post herpetic neuralgia is divided into III degree (Huang Yanshou chief editor, pain, Xi'an: People's Education Publishing House, Shaanxi, 1993.74): slight (+): patient tells pain, does not influence rest, no attitude movement response; Moderate (++): it is obvious that patient tells pain, but can stand, and no attitude movement response is had a rest in influence slightly; Severe (+++): patient tells sharp ache, is difficult to tolerance, and influence is had a rest, and can not fall asleep, and action (affected part nude) occurs escaping.
2 groups of patients' general clinical data and state of an illness contrast see Table 1:
Table 1:
Tcm syndrome differentiation and typing (Cheng Shiqi chief editor, Chinese medicine. Beijing: People's Health Publisher, 1994.178) 1. liver and gall fire Sheng type (or claiming excessive heat type, fire-toxin type): Pi Fu inflammation is red, as seen the vesicle of pimple and tonic vesicle wall, conscious scorching hot severe pain, companion's dry throat with bitter taste, the yellow urine constipation, red tongue, yellow fur, wiry and frequent pulse.2. spleen and stomach damp-heat type (damp-heat type, noxious dampness type): the patient has tangible pale vesicle, collection bunch in groups, bleb liquid muddiness, diabrosis is oozed out or is rotten to the corn, companion's pain, indigestion and loss of appetite abdominal distention, pale tongue, tongue is greasy in vain or yellow greasy, soft and rapid pulse or sliding number.3. qi stagnation and blood stasis type: deflorescence, but still gnawing pains take no rest, and it is not peaceful to sleep night, and body of the tongue is dark violet, white and thin fur, thready and stringy pulse.Treatment is organized in 315 examples, liver and gall fire Sheng type 203 examples, spleen and stomach damp-heat type 7 examples, qi stagnation and blood stasis type 105 examples.
Medicine and Therapeutic Method:
Treatment group decoct 200ml of the present invention, 2 times on the 1st, make every 200ml by the Drug Manufacturing Room of No.1 Hospital of Jilin Univ. by prescription of the present invention and contain 11.5 parts of Magnetitums, 1.5 parts of Radix Curcumaes, 7.5 parts of Folium Isatidiss, 7.5 parts of Radix Isatidiss, 1.25 parts of Fructus Gardeniaes, 2 parts of Radix Scutellariaes, 1.25 parts of Radix Bupleuri, 2 parts in the Radix Rehmanniae, 1.5 parts of Semen Plantaginiss, 1 part in Radix Glycyrrhizae, 1.75 parts of Radix Angelicae Sinensis, 2.25 parts of the Radix Paeoniae Albas.The oral somedon 0.5g of matched group (Ji Rui pharmaceutcal corporation, Ltd in Changchun produces, the date of manufacture: on November 8th, 1996), each 1,2 times on the 1st.Two groups was 1 course of treatment with 10 days all, the period in a medicine other drug of stopping using.
The result:
Criterion of therapeutical effect is cured: affected part post herpetic neuralgia symptom complete obiteration, after clinical observation half a year, there is not the recidivist.Take a turn for the better: affected part post herpetic neuralgia sx, intermittently prolong, the recidivist appears again after discontinuing medication.Invalid: through 3 more than the course of treatment treatment after, the post herpetic neuralgia symptom does not have the improver.
2 groups of efficacy results see Table 2, table 3
Table 2:
Table 3:
Treatment group curative effect and tcm syndrome differentiation and typing curative effect with liver and gall fire Sheng type and qi stagnation and blood stasis type for well.Liver and gall fire Sheng type is totally 203 examples, wherein cures 153 examples, accounts for 75.4%, and 45 examples that take a turn for the better account for 22.1%; Qi stagnation and blood stasis type is totally 105 examples, wherein cures 69 examples, accounts for 65.7%, and 32 examples that take a turn for the better account for 30.5%.
After half a year, follow up a case by regular visits to curing case, the treatment group is followed up a case by regular visits to 223 examples, recurrence 8 examples (accounting for 3.6%) after the drug withdrawal; Matched group is followed up a case by regular visits to recurrence 11 examples (accounting for 68.8%) in 16 examples, and relapse rate is with of the present invention group obviously low (P＜0.01).In addition, the matched group period in a medicine has 9 examples vomiting to occur, and erythra appears in 4 examples, amount to 13 examples (accounting for 16.5%), and the treatment group is not seen and other untoward reaction similar.
Discuss and cognition:
Motherland's medical science is thought: primary disease is many because of due to the factor affecting hepatobiliary catharsis functions such as gas, blood, wet, heat.315 routine post-herpetic neuralgia patients of clinical research of the present invention, for seeing, and spleen and stomach damp-heat type is more rare more with liver and gall fire Sheng type and qi stagnation and blood stasis type for differential diagnosis in tcm.Think that post herpetic neuralgia is that liver and gall fire is contained, due to waste heat (poison) is clear, so the present invention adopts the liver heat removing function of gallbladder promoting, eliminating fire and detoxication, removing waste heat (poison), blood circulation promoting and blood stasis dispelling, dredge the meridian passage, promoting the circulation of QI to relieve pain, general rule are bitterly method not.Magnetitum, Radix Curcumae, Folium Isatidis are monarch drug in the prescription, and Radix Isatidis, Fructus Gardeniae, Radix Scutellariae are ministerial drug, and Radix Bupleuri, the Radix Rehmanniae, Semen Plantaginis are adjuvant drug, and Radix Glycyrrhizae, Radix Angelicae Sinensis, the Radix Paeoniae Alba are messenger drug.All medicines share, and play removing fire from the liver altogether, dampness removing heat, and yin nourishing blood, depressed liver-energy dispersing and QI regulating, blood circulation promoting and blood stasis dispelling is removed waste heat (poison), to reach not bitterly merit of general rule.
Also finding in the treatment, take medicine of the present invention, can obviously shorten the course of treatment, is excellent than traditional western medicine, and medicine source abundance, and inexpensive, taking convenience is not seen toxic and side effects, is the comparatively ideal medicine of treatment primary disease.
Claims (1)
1. Chinese medicine for the treatment of post-herpetic neuralgia, wherein make the raw materials of effective components weight portion and consist of:
Magnetitum 8～15 Radix Curcumaes 1～2 Folium Isatidis 5～10
Radix Isatidis 5～10 Fructus Gardeniaes 1～1.5 Radix Scutellariae 1.5～2.5
Radix Bupleuri 1～1.5 Radix Rehmanniae 1.5～2.5 Semen Plantaginiss 1～2
Radix Glycyrrhizae 0.5～1.5 Radix Angelicae Sinensis 1.5～2 Radix Paeoniae Albas 1.5～3.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200610131664A CN101190322B (en) | 2006-11-24 | 2006-11-24 | Traditional Chinese medicine for treating zoster post herpetic neuralgia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200610131664A CN101190322B (en) | 2006-11-24 | 2006-11-24 | Traditional Chinese medicine for treating zoster post herpetic neuralgia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101190322A true CN101190322A (en) | 2008-06-04 |
| CN101190322B CN101190322B (en) | 2010-05-26 |
Family
ID=39485618
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200610131664A Expired - Fee Related CN101190322B (en) | 2006-11-24 | 2006-11-24 | Traditional Chinese medicine for treating zoster post herpetic neuralgia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101190322B (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101306186B (en) * | 2008-06-10 | 2011-09-21 | 叶明伟 | Traditional Chinese medicine taken orally for treating Qi stagnation and blood stasis type zoster |
| CN102379957A (en) * | 2010-09-03 | 2012-03-21 | 北京以岭药业有限公司 | TCM composition applied to preparation of medication for treating herpes zoster |
| CN103385937A (en) * | 2013-07-26 | 2013-11-13 | 广东省中医药工程技术研究院 | Traditional Chinese medicine preparation for preventing and treating herpes zoster and postherpetic neuralgia and preparation method thereof |
| CN106138251A (en) * | 2016-08-25 | 2016-11-23 | 颜喜贤 | A kind of Chinese medicine composition treating herpes zoster |
| CN106511890A (en) * | 2016-10-27 | 2017-03-22 | 谭奇纹 | Traditional Chinese medicine used for treating postherpetic neuralgia |
-
2006
- 2006-11-24 CN CN200610131664A patent/CN101190322B/en not_active Expired - Fee Related
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101306186B (en) * | 2008-06-10 | 2011-09-21 | 叶明伟 | Traditional Chinese medicine taken orally for treating Qi stagnation and blood stasis type zoster |
| CN102379957A (en) * | 2010-09-03 | 2012-03-21 | 北京以岭药业有限公司 | TCM composition applied to preparation of medication for treating herpes zoster |
| CN103385937A (en) * | 2013-07-26 | 2013-11-13 | 广东省中医药工程技术研究院 | Traditional Chinese medicine preparation for preventing and treating herpes zoster and postherpetic neuralgia and preparation method thereof |
| CN103385937B (en) * | 2013-07-26 | 2014-11-19 | 广东省中医药工程技术研究院 | Traditional Chinese medicine preparation for preventing and treating herpes zoster and postherpetic neuralgia and preparation method thereof |
| CN106138251A (en) * | 2016-08-25 | 2016-11-23 | 颜喜贤 | A kind of Chinese medicine composition treating herpes zoster |
| CN106511890A (en) * | 2016-10-27 | 2017-03-22 | 谭奇纹 | Traditional Chinese medicine used for treating postherpetic neuralgia |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101190322B (en) | 2010-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102233085A (en) | External application drug for treating skin diseases | |
| CN102908386A (en) | Traditional Chinese medicine for treating kidney stone | |
| CN101190322B (en) | Traditional Chinese medicine for treating zoster post herpetic neuralgia | |
| CN102688420B (en) | Traditional Chinese medicine decoction for treating psoriasis | |
| CN102078462A (en) | Asthma relieving medicament | |
| CN101062198A (en) | Decoction for treating arthritis | |
| CN101152354A (en) | Traditional Chinese medicine for treating acute dacryocystitis | |
| CN101152343A (en) | Traditional Chinese medicine for treating chronic dacryocystitis | |
| CN104587299A (en) | Traditional Chinese medicine preparation for treating gastric and duodenal ulcers | |
| CN101062273A (en) | Lily bolus for strengthening golden | |
| CN103550446B (en) | Traditional Chinese medicine composition for external use to treat rheumatoid arthritis and application of traditional Chinese medicine composition | |
| CN102349980A (en) | Traditional Chinese medicine for treating rheumatism | |
| CN101979056A (en) | Traditional Chinese medicament for treating asthma | |
| CN104288385A (en) | Drug addiction treatment traditional Chinese medicine | |
| CN1180800C (en) | A Chinese medicinal composition for treating diseases of kidney and urinary system | |
| CN103690654A (en) | Pharmaceutical composition for treating infantile diarrhea | |
| CN102626479B (en) | External-use Chinese herbal medicine composition for chronic rheumatism treatment | |
| CN1775275A (en) | External-use lotion of Chinese medicine for treating skin disease and perineum disease | |
| CN101288760B (en) | Externally-used drug for treating appendicitis | |
| CN1168464C (en) | Hepatosis treating traditional Chinese medicine | |
| CN101129965A (en) | Traditional Chinese medicine for treating chronic schistosomiasis diarrhea | |
| CN101152362A (en) | Traditional Chinese medicine for treating epidemic parotitis | |
| CN101167983A (en) | Traditional Chinese medicine for treating dacryocystitis with hidden eyes | |
| CN1293984A (en) | Medical wind for treating rheumatism | |
| CN101167916A (en) | Traditional Chinese medicine for treating chronic nasosinusitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100526 Termination date: 20111124 |